Target Name: IKZF2
NCBI ID: G22807
Review Report on IKZF2 Target / Biomarker Content of Review Report on IKZF2 Target / Biomarker
IKZF2
Other Name(s): Zinc finger protein, subfamily 1A, 2 (Helios) | MGC34330 | IKZF2 variant 2 | ZNF1A2 | Helios | ANF1A2 | zinc finger DNA binding protein Helios | OTTHUMP00000163964 | zinc finger protein, subfamily 1A, 2 (Helios) | IKAROS family zinc finger 2, transcript variant 1 | ZNFN1A2 | HELIOS | Zinc finger protein Helios | Zinc finger protein Helios (isoform 1) | IKZF2 variant 1 | Zinc finger DNA binding protein Helios | Ikaros family zinc finger protein 2 | IKAROS family zinc finger 2, transcript variant 2 | IKZF2_HUMAN | IKAROS family zinc finger 2 | Zinc finger protein Helios (isoform 2) | ikaros family zinc finger protein 2

IKZF2: A Protein Implicated in Cancer Development

IKZF2, also known as zinc finger protein subfamily 1A 2, is a protein that is expressed in various tissues throughout the body. It is a protein that plays a crucial role in cell signaling, specifically in the regulation of cell growth, differentiation, and survival. Unfortunately, despite its importance, IKZF2 has also been implicated in the development of various diseases, including cancer.

One of the main functions of IKZF2 is its role in cell signaling. IKZF2 is a transcription factor that plays a vital role in the regulation of gene expression. It is a zinc finger protein, which means that it contains a zinc finger domain in its sequence. This zinc finger domain is known to play a crucial role in the regulation of gene expression by binding to specific DNA sequences.

IKZF2 has been shown to play a role in the regulation of cell growth and differentiation. It has been shown to promote the growth and proliferation of various cell types, including cancer cells. In addition, IKZF2 has also been shown to play a role in the regulation of cell apoptosis, which is the process by which cells die naturally.

IKZF2 has also been implicated in the development of various diseases, including cancer. Studies have shown that IKZF2 is often overexpressed in various types of cancer, including breast, ovarian, and prostate cancer. This increase in IKZF2 expression has been shown to contribute to the development and progression of these diseases.

In addition to its role in cell signaling and its potential as a drug target, IKZF2 has also been shown to have potential as a biomarker. The expression of IKZF2 has been shown to be associated with the development of various diseases, including cancer. This association has led some researchers to investigate the potential of using IKZF2 as a biomarker for the diagnosis and treatment of these diseases.

In conclusion, IKZF2 is a protein that plays a crucial role in cell signaling and has been implicated in the development of various diseases, including cancer. Its zinc finger domain and its ability to promote cell growth and apoptosis make it an attractive drug target. Further research is needed to fully understand the role of IKZF2 in disease development and its potential as a biomarker.

Protein Name: IKAROS Family Zinc Finger 2

Functions: Associates with Ikaros at centromeric heterochromatin

The "IKZF2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about IKZF2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

IKZF3 | IKZF4 | IKZF5 | IL-1 Receptor | IL-10 Receptor | IL-11 receptor | IL-12 receptor | IL-13 receptor | IL-15 receptor | IL-17 Receptor | IL-2 receptor | IL-20 receptor | IL-22 Receptor | IL-23 receptor complex | IL-27 receptor | IL-3 receptor | IL-31 Receptor | IL-4 receptor | IL-5 receptor | IL-6 receptor | IL10 | IL10RA | IL10RB | IL10RB-DT | IL11 | IL11RA | IL12A | IL12A-AS1 | IL12B | IL12RB1 | IL12RB2 | IL13 | IL13RA1 | IL13RA2 | IL15 | IL15RA | IL16 | IL17A | IL17B | IL17C | IL17D | IL17F | IL17RA | IL17RB | IL17RC | IL17RD | IL17RE | IL17REL | IL18 | IL18BP | IL18R1 | IL18RAP | IL19 | IL1A | IL1B | IL1F10 | IL1R1 | IL1R2 | IL1RAP | IL1RAPL1 | IL1RAPL2 | IL1RL1 | IL1RL2 | IL1RN | IL2 | IL20 | IL20RA | IL20RB | IL21 | IL21-AS1 | IL21R | IL21R-AS1 | IL22 | IL22RA1 | IL22RA2 | IL23A | IL23R | IL24 | IL25 | IL26 | IL27 | IL27RA | IL2RA | IL2RB | IL2RG | IL3 | IL31 | IL31RA | IL32 | IL33 | IL34 | IL36A | IL36B | IL36G | IL36RN | IL37 | IL3RA | IL4 | IL4I1 | IL4R